CVRx, Inc.

MINNEAPOLIS, MN · CIK 0001235912 · Medtech · Public

Barostim, a neuromodulation device that stimulates baroreceptors to treat heart failure

barostim.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$126M
3 Form D · Jul 2020
75 months since last filing
Contracts
—
No federal contracts on record
Patents
40
28 granted · 12 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$29,626,352
Private capital raisedForm D · SEC$46,508,722
Private capital raisedForm D · SEC$50,000,000
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1943MORPHIX TECHNOLOGIES, INC.——
1944Lungpacer Medical, Inc.—$133M
1945ILLIONIX, LLC——
1946CVRx, Inc.—$126M
1947Ivenix, Inc.—$84M
1948EXAGEN INC.—$85M
1949Venus Concept Inc.—$196M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 21 related persons
  • Ali BehbahaniDirector
  • John BrintnallExecutive Officer
  • Dean Bruhn-DingExecutive Officer
  • Mike ChuisanoDirector
  • Joseph DuPayExecutive Officer
  • Elizabeth GalleExecutive Officer
  • Liz GalleExecutive Officer
  • A. GrafDirector
  • Tom HeymanDirector
  • Mudit JainDirector
  • Kadir KadhiresanDirector
  • Robert KievalDirector · Executive Officer
  • Tom MooreExecutive Officer
  • John NehraDirector
  • Kirk NielsenDirector
  • Craig PalmerExecutive Officer
  • Geoff PardoDirector
  • Josep SanfeliuDirector
  • Joseph SlatteryDirector
  • Philippe WanstokExecutive Officer
  • Nadim YaredDirector · Executive Officer

Patents

USPTO · 28 granted of 40

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.